Full View

Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro–con perspective

KS Babu, JA Kastelik, JB Morjaria - British journal of clinical …, 2014 - Wiley Online Library
Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …
被引用次数：58 相关文章

Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

KS Babu, JA Kastelik… - British Journal of Clinical …, 2014 - search.ebscohost.com
Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …

Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective

KS Babu, JA Kastelik… - British journal of clinical …, 2014 - pubmed.ncbi.nlm.nih.gov
Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …

Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

KS Babu, JA Kastelik, JB Morjaria - British Journal of Clinical …, 2014 - europepmc.org
Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …

Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro–con perspective

KS Babu, JA Kastelik, JB Morjaria - British Journal of Clinical …, 2014 - infona.pl
Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …
[HTML] nih.gov

[HTML][HTML] Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro–con perspective

KS Babu, JA Kastelik, JB Morjaria - British Journal of Clinical …, 2014 - ncbi.nlm.nih.gov
Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …